Mice from a wide variety of inbred strains (4, 7) and mice of feral origins (9) naturally form antibody against murine leukemia virus (MuLV). These antibodies against ecotropic MuLV bind to the virion but do not neutralize viral infectivity (1, 3) . Although this immune response to MuLV is widespread in mice, quantitative differences exist amongst inbred strains (4, 7) . This variation in immune response appears to be the result of several modifying factors, one of which is the immune stimulation caused by the production of endogenous MuLV (8) .
In the preceding report (8) we described that antibody production in genetic crosses between AKR and C57L mice was influenced by the production of endogenous MuLV. Mice of both the AKR and C57L strains produced low titers of anti-MuLV antibody, whereas F, hybrids produced high levels of antibody. In the C57L x (AKR x C57L)F, backcross (which segregated for the production of infectious MuLV) it was observed that immune response was correlated with the production of infectious MuLV. Mice that produced infectious MuLV also produced anti-MuLV antibodies, whereas mice that did not produce anti-MuLV antibody were of the virus-free phenotype. As a result of these findings, it was proposed that the failure of C57L mice to naturally produce anti-MuLV antibodies was due to genetic repression of immunogenic endogenous MuLV in mice of this strain. Since AKR mice continuously produced high levels of immunogenic MuLV, but did not immunologically respond to the virus, it was proposed that mice of this strain had a genetic ' RESULTS Antibodies against MuLV in the sera of AKR, C57BL/6, and F1 hybrid mice. The re-sults of RIP assays with the sera of parental C57BL/6 and AKR mice, as well as with sera from F, hybrids, are presented in Fig. 1 . Mice of both parental strains, AKR and C57BL/6, contained low titers of antibodies against MuLV. In most instances, sera of mice of these strains failed to show detectable reactions at a dilution of 1:20. In contrast, F, hybrid mice consistently had high titers of antibody against MuLV. Antibody titers of F, hybrid mice were generally greater than 1:640.
It was inferred from these findings that the AKR genome contributed the immunogenic virus to the F, hybrid, whereas the C57BL/6 genome contributed a dominant Ir gene(s). To test this hypothesis, a genetic backcross [(AKR x C57BL/6)Fi x AKR] was prepared between the F, hybrid and mice of the parental AKR strain. Mice of this backcross were uniformly positive for infectious MuLV (immunogen) but were found to segregate for C57BL/6 Ir genes.
[Eleven mice of the (AKR x C57BL/6)Fi x AKR backcross were typed for infectious ecotropic MuLV by the XC plaque assay with tail biopsies. All 11 mice contained >103 plaqueforming units (PFU)/ml of infectious MuLV.] Antibodies against MuLV in the sera of mice of the (AKR x C57BL/6)F, x AKR backcross. The results of RIP assays with the sera of Concordance of antibody titers against MuLV and the presence of Ss protein in sera.
Mice of the (AKR x C57BL/6)F, x AKR backcross were typed for the Ss protein in serum samples by immunodiffusion with a rabbit antiserum prepared against purified Ss protein. Genetic control of the production of Ss protein is closely linked (within one cross-over unit) to the H-2 and Ir-1 loci in linkage group IX (12) . Mice of the AKR strain had the Ss' allele and expressed low levels of Ss protein in their sera; mice of the C57BL/6 strain had the Ssh allele and expressed high levels of Ss protein in their sera (10) . Mice of the (AKR x C67BL/6)F, x AKR backcross were of either the Ss"' or Ssh" genotypes; sera of mice with the SSh/1 genotype contained sufficient Ss protein to form a demonstrable precipitate with anti-Ss sera, whereas sera of mice of the Ss"' genotype did not contain sufficient Ss protein to give a precipitin line.
A comparison between the Ss phenotypes and the production of antibody to MuLV in mice of the (AKR x C57BL/6)F, x gp45, p30, p17, p15, p12, and plO) . Sera from mice of the (AKR x C57BL/6)F, x AKR backcross reacted primarily with viral protein p15 (Fig. 3) . Precipitation of p15 from detergentdisrupted MuLV was observed only with sera from mice that had high titers of antibody against intact MuLV in the RIP assay. (6) , Gross virus-soluble antigen (2), leukemic cells that contain the X.1 antigen (11) , and cell-mediated immunity to Moloney virus-induced leukemias (5) . Whether all of these effects on immune response are controlled by a single gene, or by a complex locus, has not been determined. However, since the strain distribution of immune response to Gross virus-soluble antigen, to the MuLV protein p15, and to X.1 antigen does not correlate in mice of different inbred strains, it is likely that these effects are the result of a complex genetic locus.
From the findings presented here and in the accompanying report (8) , it is now possible to explain the apparent immune nonresponsiveness of mice of the C57BL/6, C57L, and AKR strains towards endogenous MuLV. Mice of the C57BL/6 and C57L strains are, in fact, capable of an immune response to MuLV, but due to the genetic repression of endogenous leukemia viruses they are not antigenically stimulated to produce antibody. In contrast, mice of the AKR strain produce immunogenic endogenous MuLV but, due to nonresponsive Ir genes, do not develop a secondary immune response to the virus.
In other studies (7) we have shown that mice of the virus-producing C58 and PL strains also do not demonstrate a secondary immune response to MuLV. Since mice of the C58 and PL strains do not produce levels of MuLV higher than that of AKR, we propose that these mice also contain nonresponsive Ir alleles. In fact, I have observed (6a) that the sera from some C58 and PL mice contain high-titered immunoglobulin M (IgM) antibodies against MuLV, although these same sera do not contain IgG antibodies against the virus. These findings are in line with the proposed model of genetic control of the immune response by an Ir gene.
It is of interest to note that mice of the low leukemic I strain produce high titers of antibody against MuLV (7). It would be predicted from these discussions that mice of the I strain would have a more frequent expression of endogenous MuLV than mice of the C57BL/6 and C57L strains. Expression of these endogenous MuLV genomes in mice of the I strain might occur at the level of (i) production of MuLV antigens in the absence of complete virions (e.g., see reference 13) or (ii) the production of poorly infectious XC-defective MuLV (e.g., U. R. Rapp and R. C. Nowinski, Proc. Natl. Acad. Sci., in press). We are presently exploring both of these possibilities.
In summary, immune response of mice to endogenous MuLV appears to be controlled by at least two factors: the production of endogenous MuLV and Ir genes that map within linkage group IX. Antibodies formed naturally to ecotropic MuLV do not neutralize the infectivity of the virion (1, 3), although these antibodies are cytotoxic for cells that produce high titers of MuLV (10) . The complexity and independent nature of these factors has obscured the relationship between the production of antibodies to MuLV and the disease susceptibility of inbred mouse strains. It is now possible, however, to determine in genetic crosses whether immune response to the MuLV protein p15 is correlated with the risk of development of spontaneous leukemia. ADDENDUM Recently, we have found that the production of antibody against MuLV in PL mice (another high leukemic strain) also is controlled by an Ir gene in linkage group IX. Seventy-nine mice of the PL x (PL x AKR)F, and the (PL x AKR)FI x PL backcrosses were examined concordantly for their production of antibody against MuLV (by the RIP assay) and for their H-2 type (by cytotoxicity assays) on lymph node cells. PL is a strain characterized with a high incidence of leukemia (due to a persistent MuLV viremia), a low production of antibody against MuLV, and the H-2U genotype; C57L is a strain with a low incidence of leukemia, a low production of antibody against MuLV, and the H-2blu genotype. High titers of antibody against MuLV in mice of this backcross were correlated with the H-2' phenotype (35/36 with RIP titers >20), whereas low titers of antibody against MuLV were correlated with the H-2ulu phenotype (32/43 with RIP titers <20). It was concluded that the production of low titers of antibody against MuLV in PL mice was the result of a genetic nonresponsiveness controlled by the Ir-1 locus in linkage group IX.
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